The proposed acquisition of Mayne Pharma by Cosette Pharmaceuticals has been terminated. The termination may have been due to rejection by the Australian government, citing national interest, although there are conflicting reports on the role of the government and the courts in the termination. Mayne Pharma has launched legal action, suggesting a dispute over the termination of the deal.